{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:24:31Z","timestamp":1778070271464,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT190298"],"award-info":[{"award-number":["PJT190298"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.mib.2024.102576","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T12:41:58Z","timestamp":1735648918000},"page":"102576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Revisiting the potential of natural products in antimycobacterial therapy: advances in drug discovery and semisynthetic solutions"],"prefix":"10.1016","volume":"83","author":[{"given":"Maya","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard D","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2024.102576_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1472-9792(02)00089-6","article-title":"Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis","volume":"83","author":"Brennan","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.mib.2024.102576_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12718-4","article-title":"Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane","volume":"7","author":"Chiaradia","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mib.2024.102576_bib3","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.molimm.2008.11.008","article-title":"Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria","volume":"46","author":"Koh","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.mib.2024.102576_bib4","unstructured":"World Health Organization. Tuberculosis: World Health Organization; 2023. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis\u3009 [Updated 7 November 2023]."},{"key":"10.1016\/j.mib.2024.102576_bib5","unstructured":"World Health Organization. Global Tuberculosis Report 2023. Geneva; 2023."},{"key":"10.1016\/j.mib.2024.102576_bib6","unstructured":"World Health Organization. Global Tuberculosis Report 2013. France; 2013."},{"key":"10.1016\/j.mib.2024.102576_bib7","first-page":"769","article-title":"Nontuberculous mycobacterial lung diseases","volume":"24","author":"Taiwo","year":"2010","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.mib.2024.102576_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2024.102576_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","article-title":"Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review","volume":"125","author":"Dahl","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.mib.2024.102576_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.mib.2024.102576_bib11","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1016\/j.bmcl.2015.07.014","article-title":"Cheminformatic comparison of approved drugs from natural product versus synthetic origins","volume":"25","author":"Stratton","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.mib.2024.102576_bib12","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.bmc.2016.06.044","article-title":"A Gestalt approach to Gram-negative entry","volume":"24","author":"Silver","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.mib.2024.102576_bib13","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/jm700967e","article-title":"Physicochemical properties of antibacterial compounds: implications for drug discovery","volume":"51","author":"O\u2019Shea","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.mib.2024.102576_sbref11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1039\/D1NP00011J","article-title":"Antimycobacterial natural products and mechanisms of action","volume":"39","author":"Han","year":"2022","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.mib.2024.102576_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(47)90087-9","article-title":"Streptomycin in tuberculosis","volume":"2","author":"Hinshaw","year":"1947","journal-title":"Am J Med"},{"key":"10.1016\/j.mib.2024.102576_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3181\/00379727-55-14461","article-title":"Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria","volume":"55","author":"Schatz","year":"1944","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.mib.2024.102576_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/jb.52.3.393-397.1946","article-title":"Isolation of Streptomycin-producing strains of Streptomyces griseus","volume":"52","author":"Waksman","year":"1946","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2024.102576_bib18","series-title":"Dictionary of Natural Products","author":"Chapman","year":"2004"},{"key":"10.1016\/j.mib.2024.102576_sbref16","doi-asserted-by":"crossref","DOI":"10.2533\/chimia.2007.327","article-title":"A simple method for high-throughput extract prefractionation for biological screening","volume":"61","author":"Appleton","year":"2007","journal-title":"CHIMIA"},{"key":"10.1016\/j.mib.2024.102576_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050625","article-title":"High-throughput screening of natural product and synthetic molecule libraries for antibacterial drug discovery","volume":"13","author":"Ayon","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.mib.2024.102576_sbref18","doi-asserted-by":"crossref","DOI":"10.1093\/jimb\/kuad042","article-title":"Lessons from assembling a microbial natural product and pre-fractionated extract library in an academic laboratory","volume":"50","author":"Cook","year":"2023","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.mib.2024.102576_bib22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nbt.3597","article-title":"Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking","volume":"34","author":"Wang","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mib.2024.102576_bib23","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1021\/acs.joc.0c00339","article-title":"Discovery of an isothiazolinone-containing antitubercular natural product levesquamide","volume":"85","author":"Liang","year":"2020","journal-title":"J Org Chem"},{"key":"10.1016\/j.mib.2024.102576_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27227794","article-title":"Discovery of levesquamide B through global natural product social molecular networking","volume":"27","author":"LeClair","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.mib.2024.102576_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking Arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.mib.2024.102576_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016869","article-title":"Decaprenylphosphoryl-\u03b2-D-ribose 2\u2032- epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis","volume":"6","author":"Crellin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mib.2024.102576_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/485439a","article-title":"Recover the lost art of drug discovery","volume":"485","author":"Lewis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102576_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41586-022-04862-3","article-title":"Biosynthetic potential of the global ocean microbiome","volume":"607","author":"Paoli","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102576_bib29","doi-asserted-by":"crossref","first-page":"e01516","DOI":"10.1128\/mBio.01516-20","article-title":"Novel antimicrobials from uncultured bacteria acting against Mycobacterium tuberculosis","volume":"11","author":"Quigley","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.mib.2024.102576_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102576_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature12959","article-title":"An environmental bacterial taxon with a large and distinct metabolic repertoire","volume":"506","author":"Wilson","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mib.2024.102576_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","article-title":"Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP dependent protease ClpC1P1P2","volume":"21","author":"Gavrish","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.mib.2024.102576_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126771","article-title":"Crystal structure of the N-terminal domain of MtClpC1 in complex with the antimycobacterial natural peptide Lassomycin","volume":"253","author":"Jagdev","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.mib.2024.102576_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.copbio.2016.04.006","article-title":"Evolving medicinal chemistry strategies in antibiotic discovery","volume":"42","author":"Pawlowski","year":"2016","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.mib.2024.102576_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/nrd1574","article-title":"Better antibiotics through chemistry","volume":"3","author":"Frantz","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mib.2024.102576_sbref33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2023.01.043","article-title":"Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents","volume":"186","author":"Zhang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.mib.2024.102576_bib37","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/AAC.00264-06","article-title":"Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible","volume":"50","author":"Andini","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2024.102576_bib38","doi-asserted-by":"crossref","first-page":"e5805","DOI":"10.1073\/pnas.1517952112","article-title":"Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus","volume":"112","author":"Eyal","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2024.102576_bib39","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aaa4690","article-title":"Targeting DnaN for tuberculosis therapy using novel griselimycins","volume":"348","author":"Kling","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mib.2024.102576_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-196207000-00004","article-title":"Actinospectacin: an in vitro study of effectiveness against pathogenic bacteria","volume":"244","author":"Hall","year":"1962","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.mib.2024.102576_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1021\/cb700100n","article-title":"A steric block in translation caused by the antibiotic spectinomycin","volume":"2","author":"Borovinskaya","year":"2007","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.mib.2024.102576_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41429-021-00408-3","article-title":"Synthesis, antibacterial action, and ribosome inhibition of deoxyspectinomycins","volume":"74","author":"Dharuman","year":"2021","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2024.102576_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102295","article-title":"Mab2780c, a TetV-like efflux pump, confers high-level spectinomycin resistance in Mycobacterium abscessus","volume":"138","author":"Hurst-Hess","year":"2023","journal-title":"Tuberculosis"},{"key":"10.1016\/j.mib.2024.102576_bib44","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1128\/AAC.06003-11","article-title":"Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates","volume":"56","author":"Balganesh","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2024.102576_sbref42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314101120","article-title":"Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus","volume":"121","author":"Phelps","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2024.102576_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm.3458","article-title":"Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux","volume":"20","author":"Lee","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2024.102576_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/acsinfecdis.6b00158","article-title":"Structure\u2013activity relationships of spectinamide antituberculosis agents: a dissection of ribosomal inhibition and native efflux avoidance contributions","volume":"3","author":"Liu","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2024.102576_sbref45","doi-asserted-by":"crossref","DOI":"10.1080\/17460441.2023.2251400","article-title":"Applications of machine learning in microbial natural product drug discovery","volume":"18","author":"Arnold","year":"2023","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.mib.2024.102576_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.aac.2024.06.003","article-title":"AI-driven drug discovery from natural products","volume":"3","author":"Duan","year":"2024","journal-title":"Adv Agrochem"},{"key":"10.1016\/j.mib.2024.102576_bib50","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","article-title":"Deep learningguided discovery of an antibiotic targeting Acinetobacter baumannii","volume":"19","author":"Liu","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.mib.2024.102576_bib51","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chembiol.2023.10.026","article-title":"Discovery of antibiotics that selectively kill metabolically dormant bacteria","volume":"31","author":"Zheng","year":"2024","journal-title":"Cell Chem Biol"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527424001528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527424001528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:29:18Z","timestamp":1771435758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527424001528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"alternative-id":["S1369527424001528"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2024.102576","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the potential of natural products in antimycobacterial therapy: advances in drug discovery and semisynthetic solutions","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2024.102576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102576"}}